Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 8/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.45 |
| ▸ | CCR5 | P51681 | 1/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8565541 | 0.95 | CHRM2 (0.54) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6168017 | 0.90 | CHRM2 (0.44) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6168606 | 0.89 | OPRL1 (0.52) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29445321 | 0.89 | OPRL1 (0.52) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6166884 | 0.89 | CHRM3 (0.51) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6167277 | 0.89 | CHRM3 (0.53) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6168220 | 0.88 | CHRM2 (0.49) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL8564439 | 0.86 | CHRM2 (0.55) | CHRM3CHRM2CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6166416 | 0.85 | CHRM3 (0.52) | CHRM3CHRM2KMT2ASIGMAR1MEN1 | |
| SCHEMBL8571871 | 0.85 | CHRM3 (0.54) | CHRM3CHRM2SIGMAR1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1122253-B1 | QUINAZOLINONE DERIVATIVES | SUMITOMO PHARMA (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-6645971-B1 | Pollakiuria and urinary incontinence treatment; muscarinic receptor antagonists; anticholinergic, anticonvulsants, antiulcer, and antiasthmatics; Parkinson*s disease | SUMITOMO PHARMACEUTICALS COMPANY LIMITED (JP) | 2003-11-11 | — | — | US | disclosed |
| EP-1122253-A1 | QUINAZOLINONE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-08-08 | — | — | EP | disclosed |